Is Pfizer Inc. overvalued?

Pfizer Inc. (PFE) looks fairly valued — trading about 5% above its fair value.

Fairly valued

Price

$26.31

Fair value

$25.05

Current P/E

19.3

Normal P/E

18.4

Market cap

$149.95B

Dividend yield

6.5%

Return on equity

4.9%

Sector

Healthcare

Fair value compares PFE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks